Trials / Conditions / Low Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
6 registered clinical trials studyying Low Grade Serous Ovarian Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients NCT06682572 | Verastem, Inc. | Phase 2 |
| Recruiting | A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer NCT06394804 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer NCT06072781 | Verastem, Inc. | Phase 3 |
| Recruiting | Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Rec NCT03564340 | Regeneron Pharmaceuticals | Phase 1 / Phase 2 |
| Active Not Recruiting | Phase I Trial of Defactinib and VS-6766. NCT03875820 | Institute of Cancer Research, United Kingdom | Phase 1 |
| Terminated | A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tub NCT01849874 | Pfizer | Phase 3 |